Form D · Biotechnology
Nexia Impact Onshore 1 LP
Sheridan, WY · CIK 0002124646
Offering snapshot reported Mar 27, 2026 · SEC filing
- Reported sold
- $6.34M Offering amount: $6.34M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Feb 19, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 27, 2026 | Initial | $6,340,000 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-577983
No Sales Commissions and Finders
Source: Form D, filed Mar 27, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David John Risbey | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
30 N Gould St Ste N
Sheridan, WY, 82801
Sheridan, WY, 82801